BioSpace News Archive

Business

Cipher Pharmaceuticals Reports Q2 2018 Results

Canadian product revenue increased 33%

August 10, 2018
·
15 min read
Deals

Astellas Announces Acquisition of Quethera

Acquisition furthers Astellas’ commitment to innovation in ophthalmology with addition of novel gene therapy program for glaucoma

August 10, 2018
·
5 min read
Prometic announces the publication of PBI-4050’s antifibrotic activity in liver diseases in Journal of Pharmacology and Experimental Therapeutics

PBI-4050 reduces the activation of hepatic stellate cells, the major cells involved in liver fibrosis

August 10, 2018
·
8 min read
Business

Array BioPharma Names Carrie S. Cox Chairman of its Board of Directors

Array BioPharma, Inc. today announced that Carrie S. Cox has been named Chairman of its Board of Directors, effective immediately.

August 10, 2018
·
6 min read
Business

Eiger BioPharmaceuticals Reports Second Quarter 2018 Financial Results

Eiger BioPharmaceuticals, Inc. announced today financial results for the three and six months ended June 30, 2018 and provided a business update.

August 10, 2018
·
9 min read
BioMidwest

Millendo Therapeutics to Participate in Upcoming August 2018 Investor Conferences

Millendo Therapeutics, Inc. announced that Julia C. Owens, Ph.D., President and Chief Executive Officer, will participate in the following August conferences:

August 10, 2018
·
1 min read
Drug Development

Cancer Discovery Highlights Potent Effects of TP Therapeutics’ Novel, Lead Investigational Compound Repotrectinib in Tumors Harboring ROS1, TRK or ALK Fusions with Solvent Front Mutations

Findings in the ongoing Phase 1/2 TRIDENT-1 Clinical Study Illustrate Potential to Overcome Drug Resistance

August 10, 2018
·
6 min read
Job Trends

The Get Grounded Foundation Awards Grants to Six Programs Serving Denver’s At-Risk Youth

GroundFloor Media (GFM) and its sister agency, CenterTable, announced the Get Grounded Foundation has awarded its latest round of community grants to six outstanding local programs supporting youth services.

August 10, 2018
·
7 min read
Biotech Bay

BioElectron Announces $40 Million Debt Financing

BioElectron Technology Corporation (BioElectron), a late clinical-stage platform biotechnology company, announced today the closing of $40 million of debt financing from Solar Capital Partners and its affiliates.

August 10, 2018
·
3 min read
Pharm Country

William Lautman Announces Trip to Zambia for Nexus Health Capital’s Sponsorship of Desperately Needed Water-Well Construction as part of Nexus Health Capital’s Corporate Social Responsibility Program Support of Golf Fore Africa

Nexus Health Capital’s Corporate Social Responsibility Program, recently announced by William Lautman, expands its scope to sponsor Golf Fore Africa to build a water-well in Zambia.

August 10, 2018
·
1 min read